CLINICAL_TRIALS
trial_result
· 2012-09-28
Clinical Trial Update: A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia. [Phase 3]
Summary
A Phase 3 trial evaluating Sativex® for relief of peripheral neuropathic pain with allodynia has completed and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jazz Pharmaceuticals | Conditions: Pain, Peripheral Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2012-09-28